Restrictive versus liberal transfusion in cardiac surgery
Which transfusion threshold best balances oxygen delivery and transfusion exposure in cardiac surgery? Compare trial populations, ischemic outcomes, mortality, and the actual thresholds used—not anemia alone.
Published studies
Open in feedRecent evidence appears first, ordered by publication date. Earlier evidence and papers without precise dates follow separately. Design categories are inferred from PubMed metadata, not evidence grades.
Showing 1 of 10 · Observational
Recent evidence · past year
-
Postoperative anaemia and long-term survival following cardiac surgery: a multicentre, retrospective, observational study.
AI summary of the abstract, unverified
- Retrospective multicentre cohort of 25,697 adult cardiac surgery patients from two Danish tertiary centres, covering 2000 to 2024.
- Anaemia at hospital discharge was classified by WHO sex-specific criteria as mild or moderate-severe, and 93.1% of patients were anaemic.
- Moderate-severe anaemia was independently associated with worse survival (adjusted HR 1.11, 95% CI 1.01-1.21, p = 0.034), while discharge haemoglobin added little prognostic information beyond baseline factors.
- Haemoglobin plateaued about 4 months after discharge but stayed below baseline at 1 year, and the authors describe the postoperative anaemia association as weak and support further trials.
Original abstract (PubMed)
INTRODUCTION: Pre-operative anaemia is associated with adverse outcomes following cardiac surgery. However, the prognostic impact of postoperative anaemia is characterised incompletely. We examined whether anaemia at hospital discharge independently predicts long-term survival and characterised haemoglobin recovery trajectories during the first postoperative year. METHODS: This retrospective multicentre cohort study included 25,697 adult cardiac surgery patients from two Danish tertiary centres (2000-2024). Anaemia was classified using World Health Organization sex-specific criteria as mild (haemoglobin 110-129 g.l-1 for men; 110-119 g.l-1 for women) or moderate-severe (haemoglobin < 110 g.l-1 for both). The primary outcome was overall survival from surgery to death or censoring at end of follow-up. Cox proportional hazards regression assessed associations between anaemia at discharge and mortality, adjusting for age, sex, pre-operative haemoglobin and comorbidities. Restricted cubic splines examined non-linear relationships between haemoglobin and mortality. RESULTS: At discharge, 23,935 (93.1%) patients were anaemic (8384 (32.6%) mild anaemia and 15,551 (60.5%) moderate-severe anaemia). Moderate-severe anaemia was independently associated with worse survival (hazard ratio 1.11, 95%CI 1.01-1.21, p = 0.034) in adjusted analysis. Cubic spline analysis revealed a steep, non-linear relationship between pre-operative haemoglobin and mortality, whereas discharge haemoglobin provided limited prognostic information beyond baseline characteristics and surgical complexity. Haemoglobin recovery plateaued around 4 months after discharge, but the average haemoglobin level remained below baseline even after 1 year. DISCUSSION: Postoperative anaemia showed a weak independent association with long-term mortality, in contrast to the clear dose-response relationship observed for pre-operative anaemia. The near-universal prevalence of postoperative anaemia and incomplete haemoglobin recovery at 1 year support further trials of peri-operative anaemia management.
PubMed 42478340 Publisher (DOI) PubMed types: Journal Article, Multicenter Study, Observational Study
Earlier evidence / dates not confirmed
Includes older studies, year-only dates, and future-dated records. Inclusion does not imply landmark status.
- No matching papers in this section with the selected filters.
Ongoing registrations
From ClinicalTrials.govRegistrations, not results. These registry entries describe ongoing studies, not their findings. They are not counted as published evidence above; check linked records for updates and associated publications.
No registered ongoing trials found.